Shangzhen Zhou

6.8k total citations
69 papers, 5.2k citations indexed

About

Shangzhen Zhou is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Shangzhen Zhou has authored 69 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Genetics, 48 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Shangzhen Zhou's work include Virus-based gene therapy research (57 papers), CAR-T cell therapy research (22 papers) and CRISPR and Genetic Engineering (19 papers). Shangzhen Zhou is often cited by papers focused on Virus-based gene therapy research (57 papers), CAR-T cell therapy research (22 papers) and CRISPR and Genetic Engineering (19 papers). Shangzhen Zhou collaborates with scholars based in United States, Canada and Australia. Shangzhen Zhou's co-authors include Katherine A. High, Glenn F. Pierce, Arun Srivastava, Federico Mingozzi, Keyun Qing, Varavani Dwarki, Valder R. Arruda, Jonathan D. Finn, Haiyan Jiang and J. Fraser Wright and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Shangzhen Zhou

68 papers receiving 5.1k citations

Peers

Countries citing papers authored by Shangzhen Zhou

Since Specialization

Citations

This map shows the geographic impact of Shangzhen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangzhen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangzhen Zhou more than expected).

Fields of papers citing papers by Shangzhen Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangzhen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangzhen Zhou. The network helps show where Shangzhen Zhou may publish in the future.

Co-authorship network of co-authors of Shangzhen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Shangzhen Zhou. A scholar is included among the top collaborators of Shangzhen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangzhen Zhou. Shangzhen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates 2019 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Michael J. Ammar, Shangzhen Zhou, Zhangyong Wei, Leona Serrano, Junwei Sun, Vivian Lee, Albert M. Maguire, Jean Bennett, Tomás S. Alemán	22
2	AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis Pigmentosa 2019 ·Molecular Therapy ·Devin S. McDougald, Tyler E. Papp, (unknown), Shangzhen Zhou, Jean Bennett	9
3	CRISPR Activation Enhances In Vitro Potency of AAV Vectors Driven by Tissue-Specific Promoters 2019 ·Molecular Therapy — Methods & Clinical Development ·Devin S. McDougald, (unknown), Katherine C. Palozola, (unknown), Tyler E. Papp, Jason A. Mills, Shangzhen Zhou, Jean Bennett	13
4	Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes 2013 ·Molecular Therapy ·Daniel J. Hui, Etiena Basner‐Tschakarjan, (unknown), Robert J. Davidson, George Buchlis, Mustafa N. Yazicioglu, Gary C. Pien, Jonathan D. Finn, Virginia Haurigot, Alex Tai, David W. Scott, Leslie P. Cousens, Shangzhen Zhou, Anne S. De Groot, Federico Mingozzi	39
5	CD8+ T Cell Recognition of Epitopes Within the Capsid of Adeno-associated Virus 8–based Gene Transfer Vectors Depends on Vectors’ Genome 2013 ·Molecular Therapy ·(unknown), Hua Li, Susan M. Faust, (unknown), Shangzhen Zhou, (unknown), Katherine A. High, Hildegund C.J. Ertl	28
6	AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models 2013 ·PLoS ONE ·Vidyullatha Vasireddy, Jason A. Mills, (unknown), Etiena Basner‐Tschakarjan, (unknown), Aaron D. Black, Kirill Alexandrov, Shangzhen Zhou, Albert M. Maguire, Daniel C. Chung, (unknown), Lisa Sullivan, Paul Gadue, Jeannette Bennicelli, Deborah L. French, Jean Bennett	62
7	Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia B 2012 ·Molecular Therapy ·Federico Mingozzi, Yifeng Chen, Samuel L. Murphy, (unknown), Alex Tai, (unknown), Mark E. Metzger, Shangzhen Zhou, J. Fraser Wright, Robert E. Donahue, Cynthia E. Dunbar, Katherine A. High	89
8	Cerebral Infusion of AAV9 Vector-encoding Non-self Proteins Can Elicit Cell-mediated Immune Responses 2012 ·Molecular Therapy ·Agnieszka Ciesielska, Piotr Hadaczek, (unknown), Shangzhen Zhou, J. Fraser Wright, Krystof S. Bankiewicz, John Forsayeth	89
9	Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B 2011 ·Frontiers in Microbiology ·Sushrusha Nayak, Debalina Sarkar, George Q. Perrin, Babak Moghimi, Brad E. Hoffman, Shangzhen Zhou, Barry J. Byrne, Roland W. Herzog	37
10	Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs 2010 ·Molecular Therapy ·Virginia Haurigot, Federico Mingozzi, George Buchlis, Daniel J. Hui, Yifeng Chen, Etiena Basner‐Tschakarjan, Valder R. Arruda, Antoneta Radu, (unknown), J. Fraser Wright, Shangzhen Zhou, Hansell H. Stedman, Dwight A. Bellinger, Timothy C. Nichols, Katherine A. High	52
11	Inhibition of Hepatitis C Virus Replication Using Adeno-Associated Virus Vector Delivery of an Exogenous Anti–Hepatitis C Virus MicroRNA Cluster 2010 ·Hepatology ·(unknown), Virginia Haurigot, Shangzhen Zhou, Guangxiang Luo, Linda B. Couto	38
12	Efficacy and Safety of Long-term Prophylaxis in Severe Hemophilia A Dogs Following Liver Gene Therapy Using AAV Vectors 2010 ·Molecular Therapy ·Denise E. Sabatino, (unknown), (unknown), Rita Sarkar, Shangzhen Zhou, Elizabeth P. Merricks, (unknown), Timothy C. Nichols, Valder R. Arruda, Haig H. Kazazian	110
13	Impact of the Underlying Mutation and the Route of Vector Administration on Immune Responses to Factor IX in Gene Therapy for Hemophilia B 2009 ·Molecular Therapy ·Ou Cao, Brad E. Hoffman, Babak Moghimi, Sushrusha Nayak, Mario Cooper, Shangzhen Zhou, Hildegund C.J. Ertl, Katherine A. High, Roland W. Herzog	84
14	Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction 2009 ·Molecular Therapy ·Jonathan D. Finn, Daniel J. Hui, (unknown), (unknown), Gary C. Pien, Federico Mingozzi, Shangzhen Zhou, Katherine A. High	88
15	Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors 2009 ·Journal of Clinical Investigation ·Gary C. Pien, Etiena Basner‐Tschakarjan, Daniel J. Hui, Ashley M. James, Jonathan D. Finn, Nicole C. Hasbrouck, Shangzhen Zhou, Samuel L. Murphy, Marcela V. Maus, Federico Mingozzi, Jordan S. Orange, Katherine A. High	151
16	Prolonged Susceptibility to Antibody-mediated Neutralization for Adeno-associated Vectors Targeted to the Liver 2007 ·Molecular Therapy ·Samuel L. Murphy, Hojun Li, Shangzhen Zhou, Alexander Schlachterman, Katherine A. High	52
17	Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy 2006 ·Blood ·Haiyan Jiang, Linda B. Couto, Susannah Patarroyo‐White, Tongyao Liu, Dea Nagy, Joseph Vargas, Shangzhen Zhou, Ciaran D. Scallan, Jürg M. Sommer, Sharmila Vijay, Federico Mingozzi, Katherine A. High, Glenn F. Pierce	276
18	Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography 2006 ·Journal of Virological Methods ·Guang Qu, (unknown), (unknown), Alex Tai, (unknown), (unknown), Jing-Min Zhou, Bernd Hauck, (unknown), Jürg M. Sommer, Peter H. Smith, Shangzhen Zhou, Peter Colosi, Katherine A. High, Glenn F. Pierce, J. Fraser Wright	132
19	Two Animal Models of Retinal Degeneration Are Rescued by Recombinant Adeno-associated Virus-Mediated Production of FGF-5 and FGF-18 2001 ·Molecular Therapy ·(unknown), Katherine G. Rendahl, Shangzhen Zhou, Martha Ladner, Mazie Coyne, Ranjana Srivastava, William C. Manning, John G. Flannery	66
20	Parvovirus B19 replication in human umbilical cord blood cells 1992 ·Virology ·C H Srivastava, Shangzhen Zhou, Nikhil C. Munshi, Arun Srivastava	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact